Copy to clipboard 
Zimmer Biomet and Hospital for Special Surgery (HSS) entered into an exclusive agreement to deploy and commercialize HSS Orthopedic Care Pathways on Zimmer Biomet’s mymobility® with Apple Watch® remote care management platform.
The mymobility with Apple Watch platform will now be accessible to clinicians and patients in the HSS network as they recover from orthopedic procedures.
HSS Orthopedic Care Pathways will debut in early 2021 and be commercially available worldwide through Zimmer Biomet in 1H21.
HSS Orthopedic Care Pathways comprise customized patient content created by HSS healthcare professionals, including pre- and post-operative care protocols, exercises, surveys, questionnaires, education materials and clinical parameters.
Zimmer Biomet’s mymobility on Apple Watch and iPhone leverages sensors to monitor a patient’s real-time activity and post-op progress. Information is delivered to the patient’s care team so they can make data-driven decisions regarding recovery and risk of complications. The system also enables virtual connections between patients and healthcare professionals throughout the surgical episode of care to lower overall costs.
Ivan Tornos, Group President for Global Businesses and the Americas at Zimmer Biomet, said, “During a time when it’s critical for healthcare professionals to find virtual approaches to safely care for and connect with patients, partnership from hospitals like HSS will help make virtual care a new standard for orthopedic patients across the globe.”
“Through mymobility with Apple Watch, HSS will help Zimmer Biomet raise standards and new possibilities for remote patient care and wellness,” said Louis A. Shapiro, President and CEO at HSS. “It is another way we are extending the reach and impact of HSS’ expertise cultivated through 157 years of specialization and continuous advancement of quality.”
Zimmer Biomet and Hospital for Special Surgery (HSS) entered into an exclusive agreement to deploy and commercialize HSS Orthopedic Care Pathways on Zimmer Biomet's mymobility® with Apple Watch® remote care management platform.
The mymobility with Apple Watch platform will now be accessible to clinicians and patients in the HSS network as...
Zimmer Biomet and Hospital for Special Surgery (HSS) entered into an exclusive agreement to deploy and commercialize HSS Orthopedic Care Pathways on Zimmer Biomet’s mymobility® with Apple Watch® remote care management platform.
The mymobility with Apple Watch platform will now be accessible to clinicians and patients in the HSS network as they recover from orthopedic procedures.
HSS Orthopedic Care Pathways will debut in early 2021 and be commercially available worldwide through Zimmer Biomet in 1H21.
HSS Orthopedic Care Pathways comprise customized patient content created by HSS healthcare professionals, including pre- and post-operative care protocols, exercises, surveys, questionnaires, education materials and clinical parameters.
Zimmer Biomet’s mymobility on Apple Watch and iPhone leverages sensors to monitor a patient’s real-time activity and post-op progress. Information is delivered to the patient’s care team so they can make data-driven decisions regarding recovery and risk of complications. The system also enables virtual connections between patients and healthcare professionals throughout the surgical episode of care to lower overall costs.
Ivan Tornos, Group President for Global Businesses and the Americas at Zimmer Biomet, said, “During a time when it’s critical for healthcare professionals to find virtual approaches to safely care for and connect with patients, partnership from hospitals like HSS will help make virtual care a new standard for orthopedic patients across the globe.”
“Through mymobility with Apple Watch, HSS will help Zimmer Biomet raise standards and new possibilities for remote patient care and wellness,” said Louis A. Shapiro, President and CEO at HSS. “It is another way we are extending the reach and impact of HSS’ expertise cultivated through 157 years of specialization and continuous advancement of quality.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
